Richard Furneaux
Board of Directors
Cancer
Avaliaimmuno Therapies
New Zealand
Biography
Richard Furneaux founded, and leads a world-renowned team of chemists at Victoria University of Wellington with a focus on the discovery and commercialization of Glycotherapeutics. Richard has established a number of international partnerships and research collaborations which have resulted in the team’s discoveries entering the clinic for treatments targeting leukaemia, lymphoma, gout, malaria and solid cancer tumours such. In additional to his research leadership he was pivotal in establishing cGMP manufacturing facility Glycosyn in 2003. Richard is a Fellow of the Royal Society of New Zealand, and was awarded its Hector Medal in 2006. He has authored 225 publications, 32 reviews and 13 published patent series. He is also the NZ representative on the International Carbohydrate Organization.
Research Interest
Cancer
